These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10598499)

  • 41. Other demyelinating diseases.
    Tselis AC; Lisak RP
    Adv Neurol; 2006; 98():335-49. PubMed ID: 16400843
    [No Abstract]   [Full Text] [Related]  

  • 42. The pathology of MS: new insights and potential clinical applications.
    Pittock SJ; Lucchinetti CF
    Neurologist; 2007 Mar; 13(2):45-56. PubMed ID: 17351524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A secondary progressive clinical course is uncommon in neuromyelitis optica.
    Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA; Weinshenker BG
    Neurology; 2007 Feb; 68(8):603-5. PubMed ID: 17310032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The spectrum of multiple sclerosis and treatment decisions.
    Siva A
    Clin Neurol Neurosurg; 2006 Mar; 108(3):333-8. PubMed ID: 16378680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lessons from the neuropathology of atypical forms of multiple sclerosis.
    Stadelmann C; Brück W
    Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Devic's syndrome (neuromyelitis optica) in the course of infiltrative pulmonary tuberculosis].
    Brzecki A; Sosnowski K; Krzysztoń Z; Mazurek S
    Gruzlica; 1975 Apr; 43(4):397-403. PubMed ID: 1123170
    [No Abstract]   [Full Text] [Related]  

  • 48. Devic's disease.
    Jain S; Hiran S; Sarma PS
    J Assoc Physicians India; 1994 Feb; 42(2):166. PubMed ID: 7860487
    [No Abstract]   [Full Text] [Related]  

  • 49. Ocular problems in early stages of multiple sclerosis.
    Roodhooft JM
    Bull Soc Belge Ophtalmol; 2009; (313):65-8. PubMed ID: 20108574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuromyelitis optica following infectious mononucleosis.
    Williamson PM
    Proc Aust Assoc Neurol; 1975; 12():153-5. PubMed ID: 1215384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nature of multiple sclerosis.
    Poser CM; Brinar VV
    Clin Neurol Neurosurg; 2004 Jun; 106(3):159-71. PubMed ID: 15177764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.
    Murta V; Ferrari CC
    Mol Cell Neurosci; 2013 Mar; 53():6-13. PubMed ID: 22771835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuromyelitis optica or Devic disease complicating chickenpox (author's transl)].
    Bruguier A; Ponsot G; Khouri-Dagher L; de Leersnyder H
    Arch Fr Pediatr; 1981 Dec; 38(10):763-4. PubMed ID: 7332418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromyelitis optica: what it is and what it might be.
    Weinshenker BG
    Lancet; 2003 Mar; 361(9361):889-90. PubMed ID: 12648964
    [No Abstract]   [Full Text] [Related]  

  • 55. [A unusual manifestation of multiple sclerosis: sciatica].
    Giroud M; Guard O; Audry D; Soichot P; Dumas R
    Ann Med Interne (Paris); 1985; 136(7):566-71. PubMed ID: 3004282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Injuries in the etiopathogenesis of multiple sclerosis].
    Rudez J; Antonelli L; Materljan E; Sepcić J
    Lijec Vjesn; 1998; 120(1-2):24-7. PubMed ID: 9650482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rare inflammatory diseases of the white matter and mimics of multiple sclerosis and related disorders.
    Tardieu M; Deiva K
    Neuropediatrics; 2013 Dec; 44(6):302-8. PubMed ID: 24166147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is neuromyelitis optica eyeing a distinct path from multiple sclerosis?
    Glisson CC; Galetta SL
    Arch Ophthalmol; 2008 Jan; 126(1):128-9. PubMed ID: 18195231
    [No Abstract]   [Full Text] [Related]  

  • 59. Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy.
    Lassmann H
    J Neurol Sci; 2011 Jul; 306(1-2):167-9. PubMed ID: 20719338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral nerve abnormalities in multiple sclerosis.
    Waxman SG
    Muscle Nerve; 1993 Jan; 16(1):1-5. PubMed ID: 8380899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.